A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated LiposarcomaChristina V. Angeles, Samuel Singer, Ana Velez et al.|Clinical Cancer Research|2021Cited by 14
Figure S1 from A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated LiposarcomaChristina V. Angeles, Samuel Singer, Ana Velez et al.|Unknown|2023Cited by 0
Figure S4 from A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated LiposarcomaChristina V. Angeles, Samuel Singer, Jordan Rios et al.|Unknown|2023Cited by 0
Figure S3 from A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated LiposarcomaChristina V. Angeles, Samuel Singer, Ana Velez et al.|Unknown|2023Cited by 0
Supplementary Table 1 from A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated LiposarcomaChristina V. Angeles, Samuel Singer, Ana Velez et al.|Unknown|2023Cited by 0